UBS reiterates Buy on Darden stock ahead of earnings report

UBS reiterated its Buy rating on Darden Restaurants with a $240 price target, implying roughly 15% upside from the $208.45 share price, ahead of fiscal Q1 2027 earnings on September 24. UBS expects LongHorn same-store sales to outperform the 5.9% consensus forecast, while Olive Garden sales may lag the 1.9% consensus; EPS is expected to be slightly below the $2.05 sell-side estimate. Darden is expected to reiterate FY2027 guidance for $13.6-$13.75B in sales, 2.5%-3.5% same-store-sales growth, and adjusted EPS of $11.10-$11.35, though investor concerns remain centered on Olive Garden demand and inflation pressure.

Analysis

The setup is less about consolidated sales than whether Darden can preserve earnings quality while its largest concept absorbs a softer traffic mix. LongHorn’s strength supports check and mix, but it also raises beef-cost sensitivity; a renewed cattle-price move would pressure restaurant-level margins just as Olive Garden likely requires incremental promotional spending. Firm inflation and a more restrictive-rate backdrop further skew near-term traffic risk toward middle-income diners, making a weak Olive Garden print more consequential to the multiple than a LongHorn beat is supportive.

Expectations appear bifurcated rather than uniformly bearish: channel checks imply a modest EPS miss is already plausible, while the upside case relies on guidance durability and evidence that promotion-driven traffic is incremental rather than cannibalizing future visits. At roughly 18.5x forecast FY2027 EPS, DRI is not priced for a material guidance reduction, but the $240 bull case requires a rerating above 21x. The key 1-3 month catalyst is not the quarter itself, but management’s read on post-promotion Olive Garden traffic and commodity/labor assumptions for the following quarter.

Contrarianly, the market may be underestimating Darden’s ability to use scale and marketing to take share from independents if consumer demand slows, but that is a 6-18 month thesis and does not immunize the stock from a near-term multiple reset. Analyst channel checks and price-target changes are not independently verifiable evidence of demand; confirmation should come from traffic, restaurant-level margin, and unchanged full-year EPS guidance rather than a headline EPS result.

Key Decisions for Investors

• Do not add directional risk ahead of the September 24 report solely on analyst commentary; establish a post-earnings alert if DRI holds or reclaims $208 after management confirms full-year EPS guidance and reports Olive Garden comparable sales at least flat.
• Conditional long DRI: buy in the $198-203 range following a guidance reiteration, targeting $230-240 over 3-6 months; risk is approximately 5-7% to a $190 stop versus 14-20% upside. Exit if Olive Garden comps are negative and management lowers either same-store-sales or EPS guidance.
• For a defensive relative-value expression, consider long DRI / short a broad discretionary restaurant basket such as XRT only after confirmed share gains; Darden’s scale should outperform smaller operators in a slowing traffic environment, while the pair avoids some macro-rate exposure. Reassess if beef and wage inflation accelerate simultaneously, since DRI’s LongHorn mix then becomes a margin liability.
• Monitor cattle futures, wage commentary, and Olive Garden traffic through the promotion period as the highest-value data points. A sustained input-cost increase or evidence that promotion is discounting existing guests—not adding visits—would invalidate the margin-resilience thesis within one to two quarters.